{"id":22188,"date":"2020-01-24T16:50:14","date_gmt":"2020-01-24T15:50:14","guid":{"rendered":"https:\/\/faus-moliner.com\/a-proposito-del-plan-de-accion-para-fomentar-la-utilizacion-de-los-medicamentos-reguladores-del-mercado-en-el-sns-medicamentos-biosimilares-y-medicamentos-genericos\/"},"modified":"2020-02-03T17:00:04","modified_gmt":"2020-02-03T16:00:04","slug":"a-proposito-del-plan-de-accion-para-fomentar-la-utilizacion-de-los-medicamentos-reguladores-del-mercado-en-el-sns-medicamentos-biosimilares-y-medicamentos-genericos","status":"publish","type":"post","link":"https:\/\/faus-moliner.com\/en\/a-proposito-del-plan-de-accion-para-fomentar-la-utilizacion-de-los-medicamentos-reguladores-del-mercado-en-el-sns-medicamentos-biosimilares-y-medicamentos-genericos\/","title":{"rendered":"About the \u201cAction Plan to promote the use of market regulatory medicines in the NHS: biosimilar and generic products\u201d"},"content":{"rendered":"\n

The Spanish Ministry of Health has published its proposal of an Action Plan to foster the use of biosimilar and generic products,
\nreferring to them as medicinal products that regulate the market within the Spanish National Health System. This article comprises some
\nof the ideas that Faus & Moliner put forward in a personal and independent contribution iled during the period of public consultation of
\nthis document..<\/p>\n","protected":false},"excerpt":{"rendered":"

The Spanish Ministry of Health has published its proposal of an Action Plan to foster the use of biosimilar and generic products, referring to them as medicinal products that regulate the market within the Spanish National Health System. This article comprises some of the ideas that Faus & Moliner put forward in a personal and… <\/p>\n

<\/div>\n

Read More<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[71,1],"tags":[],"coauthors":[],"class_list":["post-22188","post","type-post","status-publish","format-standard","hentry","category-publications","category-uncategorized"],"acf":[],"yoast_head":"\nAbout the \u201cAction Plan to promote the use of market regulatory medicines in the NHS: biosimilar and generic products\u201d - Faus Moliner<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/faus-moliner.com\/en\/a-proposito-del-plan-de-accion-para-fomentar-la-utilizacion-de-los-medicamentos-reguladores-del-mercado-en-el-sns-medicamentos-biosimilares-y-medicamentos-genericos\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"About the \u201cAction Plan to promote the use of market regulatory medicines in the NHS: biosimilar and generic products\u201d - Faus Moliner\" \/>\n<meta property=\"og:description\" content=\"The Spanish Ministry of Health has published its proposal of an Action Plan to foster the use of biosimilar and generic products, referring to them as medicinal products that regulate the market within the Spanish National Health System. This article comprises some of the ideas that Faus & Moliner put forward in a personal and... Read More\" \/>\n<meta property=\"og:url\" content=\"https:\/\/faus-moliner.com\/en\/a-proposito-del-plan-de-accion-para-fomentar-la-utilizacion-de-los-medicamentos-reguladores-del-mercado-en-el-sns-medicamentos-biosimilares-y-medicamentos-genericos\/\" \/>\n<meta property=\"og:site_name\" content=\"Faus Moliner\" \/>\n<meta property=\"article:published_time\" content=\"2020-01-24T15:50:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-02-03T16:00:04+00:00\" \/>\n<meta name=\"author\" content=\"Jordi Faus\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jordi Faus\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/faus-moliner.com\/en\/a-proposito-del-plan-de-accion-para-fomentar-la-utilizacion-de-los-medicamentos-reguladores-del-mercado-en-el-sns-medicamentos-biosimilares-y-medicamentos-genericos\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/a-proposito-del-plan-de-accion-para-fomentar-la-utilizacion-de-los-medicamentos-reguladores-del-mercado-en-el-sns-medicamentos-biosimilares-y-medicamentos-genericos\/\"},\"author\":{\"name\":\"Jordi Faus\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/da4b76d949932369d90eaa21ed440260\"},\"headline\":\"About the \u201cAction Plan to promote the use of market regulatory medicines in the NHS: biosimilar and generic products\u201d\",\"datePublished\":\"2020-01-24T15:50:14+00:00\",\"dateModified\":\"2020-02-03T16:00:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/a-proposito-del-plan-de-accion-para-fomentar-la-utilizacion-de-los-medicamentos-reguladores-del-mercado-en-el-sns-medicamentos-biosimilares-y-medicamentos-genericos\/\"},\"wordCount\":86,\"publisher\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#organization\"},\"articleSection\":[\"Publications\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/faus-moliner.com\/en\/a-proposito-del-plan-de-accion-para-fomentar-la-utilizacion-de-los-medicamentos-reguladores-del-mercado-en-el-sns-medicamentos-biosimilares-y-medicamentos-genericos\/\",\"url\":\"https:\/\/faus-moliner.com\/en\/a-proposito-del-plan-de-accion-para-fomentar-la-utilizacion-de-los-medicamentos-reguladores-del-mercado-en-el-sns-medicamentos-biosimilares-y-medicamentos-genericos\/\",\"name\":\"About the \u201cAction Plan to promote the use of market regulatory medicines in the NHS: biosimilar and generic products\u201d - Faus Moliner\",\"isPartOf\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#website\"},\"datePublished\":\"2020-01-24T15:50:14+00:00\",\"dateModified\":\"2020-02-03T16:00:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/a-proposito-del-plan-de-accion-para-fomentar-la-utilizacion-de-los-medicamentos-reguladores-del-mercado-en-el-sns-medicamentos-biosimilares-y-medicamentos-genericos\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/faus-moliner.com\/en\/a-proposito-del-plan-de-accion-para-fomentar-la-utilizacion-de-los-medicamentos-reguladores-del-mercado-en-el-sns-medicamentos-biosimilares-y-medicamentos-genericos\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/faus-moliner.com\/en\/a-proposito-del-plan-de-accion-para-fomentar-la-utilizacion-de-los-medicamentos-reguladores-del-mercado-en-el-sns-medicamentos-biosimilares-y-medicamentos-genericos\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/faus-moliner.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"About the \u201cAction Plan to promote the use of market regulatory medicines in the NHS: biosimilar and generic products\u201d\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#website\",\"url\":\"https:\/\/faus-moliner.com\/en\/\",\"name\":\"faus-moliner.com\",\"description\":\"Otro sitio realizado con WordPress\",\"publisher\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/faus-moliner.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#organization\",\"name\":\"Faus Moliner\",\"url\":\"https:\/\/faus-moliner.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg\",\"contentUrl\":\"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg\",\"width\":400,\"height\":283,\"caption\":\"Faus Moliner\"},\"image\":{\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/2372042\/admin\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/da4b76d949932369d90eaa21ed440260\",\"name\":\"Jordi Faus\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/image\/f7cb308a9e6d6fe5434c7ca47ff11be5\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/896c20951cba2f462a35f9a554d612f00999b71a73a0ad6a1625c27912d34e52?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/896c20951cba2f462a35f9a554d612f00999b71a73a0ad6a1625c27912d34e52?s=96&d=mm&r=g\",\"caption\":\"Jordi Faus\"},\"description\":\"Jordi Faus graduated in Law at the Autonomous University of Barcelona (1986) and obtained a degree in Advanced Legal European Studies at the College of Europe in Bruges, Belgium (1987). He also has completed an Executive Management Programme at IESE Business School, in Barcelona.\",\"sameAs\":[\"https:\/\/faus-moliner.com\/\"],\"url\":\"https:\/\/faus-moliner.com\/en\/author\/jordi-faus\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"About the \u201cAction Plan to promote the use of market regulatory medicines in the NHS: biosimilar and generic products\u201d - Faus Moliner","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/faus-moliner.com\/en\/a-proposito-del-plan-de-accion-para-fomentar-la-utilizacion-de-los-medicamentos-reguladores-del-mercado-en-el-sns-medicamentos-biosimilares-y-medicamentos-genericos\/","og_locale":"en_US","og_type":"article","og_title":"About the \u201cAction Plan to promote the use of market regulatory medicines in the NHS: biosimilar and generic products\u201d - Faus Moliner","og_description":"The Spanish Ministry of Health has published its proposal of an Action Plan to foster the use of biosimilar and generic products, referring to them as medicinal products that regulate the market within the Spanish National Health System. This article comprises some of the ideas that Faus & Moliner put forward in a personal and... Read More","og_url":"https:\/\/faus-moliner.com\/en\/a-proposito-del-plan-de-accion-para-fomentar-la-utilizacion-de-los-medicamentos-reguladores-del-mercado-en-el-sns-medicamentos-biosimilares-y-medicamentos-genericos\/","og_site_name":"Faus Moliner","article_published_time":"2020-01-24T15:50:14+00:00","article_modified_time":"2020-02-03T16:00:04+00:00","author":"Jordi Faus","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Jordi Faus"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/faus-moliner.com\/en\/a-proposito-del-plan-de-accion-para-fomentar-la-utilizacion-de-los-medicamentos-reguladores-del-mercado-en-el-sns-medicamentos-biosimilares-y-medicamentos-genericos\/#article","isPartOf":{"@id":"https:\/\/faus-moliner.com\/en\/a-proposito-del-plan-de-accion-para-fomentar-la-utilizacion-de-los-medicamentos-reguladores-del-mercado-en-el-sns-medicamentos-biosimilares-y-medicamentos-genericos\/"},"author":{"name":"Jordi Faus","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/da4b76d949932369d90eaa21ed440260"},"headline":"About the \u201cAction Plan to promote the use of market regulatory medicines in the NHS: biosimilar and generic products\u201d","datePublished":"2020-01-24T15:50:14+00:00","dateModified":"2020-02-03T16:00:04+00:00","mainEntityOfPage":{"@id":"https:\/\/faus-moliner.com\/en\/a-proposito-del-plan-de-accion-para-fomentar-la-utilizacion-de-los-medicamentos-reguladores-del-mercado-en-el-sns-medicamentos-biosimilares-y-medicamentos-genericos\/"},"wordCount":86,"publisher":{"@id":"https:\/\/faus-moliner.com\/en\/#organization"},"articleSection":["Publications"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/faus-moliner.com\/en\/a-proposito-del-plan-de-accion-para-fomentar-la-utilizacion-de-los-medicamentos-reguladores-del-mercado-en-el-sns-medicamentos-biosimilares-y-medicamentos-genericos\/","url":"https:\/\/faus-moliner.com\/en\/a-proposito-del-plan-de-accion-para-fomentar-la-utilizacion-de-los-medicamentos-reguladores-del-mercado-en-el-sns-medicamentos-biosimilares-y-medicamentos-genericos\/","name":"About the \u201cAction Plan to promote the use of market regulatory medicines in the NHS: biosimilar and generic products\u201d - Faus Moliner","isPartOf":{"@id":"https:\/\/faus-moliner.com\/en\/#website"},"datePublished":"2020-01-24T15:50:14+00:00","dateModified":"2020-02-03T16:00:04+00:00","breadcrumb":{"@id":"https:\/\/faus-moliner.com\/en\/a-proposito-del-plan-de-accion-para-fomentar-la-utilizacion-de-los-medicamentos-reguladores-del-mercado-en-el-sns-medicamentos-biosimilares-y-medicamentos-genericos\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/faus-moliner.com\/en\/a-proposito-del-plan-de-accion-para-fomentar-la-utilizacion-de-los-medicamentos-reguladores-del-mercado-en-el-sns-medicamentos-biosimilares-y-medicamentos-genericos\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/faus-moliner.com\/en\/a-proposito-del-plan-de-accion-para-fomentar-la-utilizacion-de-los-medicamentos-reguladores-del-mercado-en-el-sns-medicamentos-biosimilares-y-medicamentos-genericos\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/faus-moliner.com\/en\/"},{"@type":"ListItem","position":2,"name":"About the \u201cAction Plan to promote the use of market regulatory medicines in the NHS: biosimilar and generic products\u201d"}]},{"@type":"WebSite","@id":"https:\/\/faus-moliner.com\/en\/#website","url":"https:\/\/faus-moliner.com\/en\/","name":"faus-moliner.com","description":"Otro sitio realizado con WordPress","publisher":{"@id":"https:\/\/faus-moliner.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/faus-moliner.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/faus-moliner.com\/en\/#organization","name":"Faus Moliner","url":"https:\/\/faus-moliner.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg","contentUrl":"https:\/\/faus-moliner.com\/wp-content\/uploads\/2023\/03\/Logo-FM-web.jpg","width":400,"height":283,"caption":"Faus Moliner"},"image":{"@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/2372042\/admin\/"]},{"@type":"Person","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/da4b76d949932369d90eaa21ed440260","name":"Jordi Faus","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/faus-moliner.com\/en\/#\/schema\/person\/image\/f7cb308a9e6d6fe5434c7ca47ff11be5","url":"https:\/\/secure.gravatar.com\/avatar\/896c20951cba2f462a35f9a554d612f00999b71a73a0ad6a1625c27912d34e52?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/896c20951cba2f462a35f9a554d612f00999b71a73a0ad6a1625c27912d34e52?s=96&d=mm&r=g","caption":"Jordi Faus"},"description":"Jordi Faus graduated in Law at the Autonomous University of Barcelona (1986) and obtained a degree in Advanced Legal European Studies at the College of Europe in Bruges, Belgium (1987). He also has completed an Executive Management Programme at IESE Business School, in Barcelona.","sameAs":["https:\/\/faus-moliner.com\/"],"url":"https:\/\/faus-moliner.com\/en\/author\/jordi-faus\/"}]}},"_links":{"self":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/posts\/22188","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/comments?post=22188"}],"version-history":[{"count":0,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/posts\/22188\/revisions"}],"wp:attachment":[{"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/media?parent=22188"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/categories?post=22188"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/tags?post=22188"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/faus-moliner.com\/en\/wp-json\/wp\/v2\/coauthors?post=22188"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}